Patents by Inventor Evan S. Luxon
Evan S. Luxon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240024142Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: ApplicationFiled: October 2, 2023Publication date: January 25, 2024Applicant: Bone Health Technologies, Inc.Inventors: Daniel R. BURNETT, Shane MANGRUM, Timothy TIGNER, Evan S. LUXON, Marcie HAMILTON, Alex YEE
-
Patent number: 11806262Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: GrantFiled: December 7, 2021Date of Patent: November 7, 2023Assignee: Bone Health Technologies, Inc.Inventors: Daniel R. Burnett, Shane Mangrum, Timothy Tigner, Evan S. Luxon, Marcie Hamilton, Alex Yee, Jose Gutierrez
-
Publication number: 20230320660Abstract: Devices and methods for monitoring physiologic parameters are described where an airway device, in one embodiment, may comprise a mouthpiece section and an opening section defining one or more airway lumens therethrough with a first sensor in fluid communication with the one or more airway lumens and a second sensor positioned upon a hand-piece for contact against a portion of the user. The first sensor may be configured to detect an airway pressure when a user inhales or exhales through the one or more airway lumens, and the second sensor may be configured to detect a physiological signal from the user. Additionally, a controller may be in communication with the first and second sensors where the controller is programmed to correlate pressure oscillations in the airway pressure with heartbeats.Type: ApplicationFiled: June 2, 2023Publication date: October 12, 2023Applicant: Respirix, Inc.Inventors: Evan S. LUXON, Daniel R. BURNETT, Alexander VERGARA, Mark ZIEGLER, Nikhil VISWANATHAN, Michael HEMATI
-
Patent number: 11707227Abstract: Devices and methods for monitoring physiologic parameters are described where an airway device, in one embodiment, may comprise a mouthpiece section and an opening section defining one or more airway lumens therethrough with a first sensor in fluid communication with the one or more airway lumens and a second sensor positioned upon a hand-piece for contact against a portion of the user. The first sensor may be configured to detect an airway pressure when a user inhales or exhales through the one or more airway lumens, and the second sensor may be configured to detect a physiological signal from the user. Additionally, a controller may be in communication with the first and second sensors where the controller is programmed to correlate pressure oscillations in the airway pressure with heartbeats.Type: GrantFiled: January 5, 2018Date of Patent: July 25, 2023Assignee: Respirix, Inc.Inventors: Evan S. Luxon, Daniel R. Burnett, Alexander Vergara, Mark Ziegler, Nikhil Viswanathan, Michael Hemati
-
Patent number: 11679196Abstract: Disclosed is a chest drainage system which reduces or eliminates pooling of blood/liquid and/or clogging/clotting in the drainage tube. Generally, the chest drainage system continuously monitors chest tube status and clears pooled liquid when necessary to restore negative pressure to the chest. The system may include a valve device which is located between the patient's chest tube and drainage tube and may be used with any standard chest tube. The chest drainage system also includes a controller for monitoring the pressure at or near the valve device and/or at or near the suction device, and possibly a pump for assisting in clearance of pooled liquid and/or clots. The controller may also control the valve device and/or suction device in response to pressure signals.Type: GrantFiled: June 3, 2020Date of Patent: June 20, 2023Assignee: Centese, Inc.Inventors: Evan S. Luxon, Daniel R. Burnett, Mark Ziegler
-
Publication number: 20220355018Abstract: Devices and methods for managing chest or wound drainage are disclosed where in one embodiment, the system generally comprises a chest tube configured for insertion at least partially within a body of a subject, a drainage tube fluidly coupled with the chest tube, a reservoir fluidly coupled with the drainage tube, a pump in communication with the reservoir, and a controller in fluid communication with the drainage tube. The controller may be configured to determine a readiness for removal of the chest tube from the body based upon one or more removal parameters which are obtained over a period of time via the controller.Type: ApplicationFiled: July 20, 2022Publication date: November 10, 2022Applicant: Centese, Inc.Inventors: Evan S. LUXON, Ryan COUGHLIN, Randy PRESTON, Ryan BEHRINGER, Kyle FITCH, Nicholas WANT
-
Publication number: 20220167910Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: ApplicationFiled: February 18, 2022Publication date: June 2, 2022Applicant: Gravitas Medical, Inc.Inventors: Daniel R. BURNETT, Marcie HAMILTON, Evan S. LUXON, Alexander VERGARA, Saheel SUTARIA
-
Patent number: 11284832Abstract: Devices and methods to measure gastric residual volume (GRV) are described where at least one additive component (a GRV indicator) may be dispersed in a body lumen such as a stomach. The GRV indicator may changes a physical (chemical, electrical, thermal, mechanical, optical, etc.) characteristic within the stomach by a measureable degree. This degree of change and/or the rate of return to the previous state, may be used to determine the GRV of a patient. The determined GRV can also be used to automatically or semi-automatically control the patient's feeding rate and/or volume and/or frequency to adequately nourish the patient but avoid complications. The physical characteristic(s) may also be used to detect that the feeding catheter or tube is in the correct location (ie stomach vs lung or esophagus.Type: GrantFiled: July 28, 2016Date of Patent: March 29, 2022Assignee: Gravitas Medical, Inc.Inventors: Daniel R. Burnett, Marcie Hamilton, Evan S. Luxon, Alexander Vergara, Saheel Sutaria
-
Publication number: 20220087844Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: ApplicationFiled: December 7, 2021Publication date: March 24, 2022Applicant: TheraNova, LLCInventors: Daniel R. BURNETT, Shane MANGRUM, Timothy TIGNER, Evan S. LUXON, Marcie HAMILTON, Alex YEE, Jose GUTIERREZ
-
Publication number: 20220075208Abstract: Embodiments of the technology relate to a contact lens having a core that is covalently coated by a hydrogel layer, and to methods of making such a lens. In one aspect, embodiments provide for a coated contact lens comprising a lens core comprising an outer surface; and a hydrogel layer covalently attached to at least a portion of the outer surface, the hydrogel layer adapted to contact an ophthalmic surface, wherein the hydrogel layer comprises a hydrophilic polymer population having a first PEG species and a second PEG species, the first PEG species being at least partially cross-linked to the second PEG species.Type: ApplicationFiled: November 19, 2021Publication date: March 10, 2022Inventors: Karen L. HAVENSTRITE, Victor Wayne MCCRAY, Brandon McNary FELKINS, Douglas Michael ACKERMANN, Garrett Cale SMITH, Paul A. COOK, Evan S. LUXON, Andrew A. MCGIBBON
-
Patent number: 11219542Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: GrantFiled: November 9, 2020Date of Patent: January 11, 2022Assignee: TheraNova, LLCInventors: Daniel R. Burnett, Shane Mangrum, Timothy Tigner, Evan S. Luxon, Marcie Hamilton, Alex Yee, Jose Gutierrez
-
Patent number: 11181754Abstract: Embodiments of the technology relate to a contact lens having a core that is covalently coated by a hydrogel layer, and to methods of making such a lens. In one aspect, embodiments provide for a coated contact lens comprising a lens core comprising an outer surface; and a hydrogel layer covalently attached to at least a portion of the outer surface, the hydrogel layer adapted to contact an ophthalmic surface, wherein the hydrogel layer comprises a hydrophilic polymer population having a first PEG species and a second PEG species, the first PEG species being at least partially cross-linked to the second PEG species.Type: GrantFiled: October 4, 2019Date of Patent: November 23, 2021Assignee: Tangible Science, LLCInventors: Karen L. Havenstrite, Victor Wayne McCray, Brandon McNary Felkins, Douglas Michael Ackermann, Garrett Cale Smith, Paul A. Cook, Evan S. Luxon, Andrew A. McGibbon
-
Publication number: 20210236004Abstract: Devices and methods for monitoring physiologic parameters are described herein which may utilize a non-invasive respiratory monitor to detect minor variations in expiratory airflow pressure known as cardiogenic oscillations which are generated by changes in the pulmonary blood volume that correspond with the cardiac cycle. These cardiogenic oscillations are a direct indicator of cardiac function and may be used to correlate various physiologic parameters such as stroke volume, pulmonary artery pressure, etc.Type: ApplicationFiled: April 19, 2021Publication date: August 5, 2021Applicant: Respirix, Inc.Inventors: Evan S. LUXON, Daniel R. BURNETT, Stephen BOYD
-
Patent number: 11026824Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: GrantFiled: January 3, 2019Date of Patent: June 8, 2021Assignee: TheraNova, LLCInventors: Daniel R. Burnett, Shane Mangrum, Timothy Tigner, Evan S. Luxon, Marcie Hamilton, Alex Yee, Jose Gutierrez
-
Publication number: 20210154378Abstract: Disclosed is a chest drainage system which reduces or eliminates pooling of blood/liquid and/or clogging/clotting in the drainage tube. Generally, the chest drainage system continuously monitors chest tube status and clears pooled liquid when necessary to restore negative pressure to the chest. The system may include a valve device which is located between the patient's chest tube and drainage tube and may be used with any standard chest tube. The chest drainage system also includes a controller for monitoring the pressure at or near the valve device and/or at or near the suction device, and possibly a pump for assisting in clearance of pooled liquid and/or clots. The controller may also control the valve device and/or suction device in response to pressure signals.Type: ApplicationFiled: February 1, 2021Publication date: May 27, 2021Applicant: Centese, Inc.Inventors: Evan S. LUXON, Daniel R. BURNETT, Mark ZIEGLER
-
Publication number: 20210145294Abstract: Devices and methods for monitoring physiologic parameters are described herein which may utilize a non-invasive respiratory monitor to detect minor variations in expiratory airflow pressure known as cardiogenic oscillations which are generated by changes in the pulmonary blood volume that correspond with the cardiac cycle. These cardiogenic oscillations are a direct indicator of cardiac function and may be used to correlate various physiologic parameters such as stroke volume, pulmonary artery pressure, etc.Type: ApplicationFiled: January 26, 2021Publication date: May 20, 2021Applicant: Respirix, Inc.Inventors: Evan S. LUXON, Daniel R. BURNETT, Stephen BOYD
-
Patent number: 10932674Abstract: Devices and methods for monitoring physiologic parameters are described herein which may utilize a non-invasive respiratory monitor to detect minor variations in expiratory airflow pressure known as cardiogenic oscillations which are generated by changes in the pulmonary blood volume that correspond with the cardiac cycle. These cardiogenic oscillations are a direct indicator of cardiac function and may be used to correlate various physiologic parameters such as stroke volume, pulmonary artery pressure, etc.Type: GrantFiled: April 28, 2017Date of Patent: March 2, 2021Assignee: Respirix, Inc.Inventors: Evan S. Luxon, Daniel R. Burnett, Stephen Boyd
-
Publication number: 20210052407Abstract: A wearable apparatus for the treatment or prevention of osteopenia or osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is disclosed where the apparatus may generally comprise one or more vibrating elements configured for imparting repeated mechanical loads to the hip, femur, and/or spine of an individual at a frequency and acceleration sufficient for therapeutic effect. These vibrating elements may be secured to the upper body of an individual via one or more respective securing mechanisms, where the securing mechanisms are configured to position the one or more vibrating elements in a direction lateral to the individual, and the position, tension, and efficacy of these vibrating elements may be monitored and/or regulated by one or more accelerometers.Type: ApplicationFiled: November 9, 2020Publication date: February 25, 2021Applicant: TheraNova, LLCInventors: Daniel R. BURNETT, Shane MANGRUM, Timothy TIGNER, Evan S. LUXON, Marcie HAMILTON, Alex YEE, Jose GUTIERREZ
-
Publication number: 20200397956Abstract: Devices and methods for managing chest drainage include a drainage system with a chest tube having a chest tube drainage lumen and a drainage reservoir in fluid communication with the chest tube drainage lumen. A pump may be in fluid communication with the chest tube drainage lumen and a pressure sensor may be positioned proximal to the chest tube and in communication with the chest tube drainage lumen. A controller may be in communication with the pressure sensor and the pump, wherein the controller is configured to actuate the pump at a first suction level sufficient to drain a fluid from the chest tube drainage lumen. The controller is further configured to actuate the pump at a second suction level which is different from the first suction level such that an absence of attenuation in the second suction level over time is indicative of an obstruction in the chest tube.Type: ApplicationFiled: August 31, 2020Publication date: December 24, 2020Applicant: Centese, Inc.Inventors: Evan S. LUXON, Ryan COUGHLIN, Ryan BEHRINGER, Kyle FITCH, Randy PRESTON, Daniel R. BURNETT, Mark ZIEGLER
-
Publication number: 20200384167Abstract: A device for draining bodily fluids is described herein which generally may comprise an elongate body defining one or more lumens configured to receive a bodily fluid from a cavity, e.g., bladder, of a patient body. The one or more lumens are in fluid communication with a reservoir which may receive the bodily fluid. A pumping mechanism may be used to urge the bodily fluid through the one or more lumens, where the pumping mechanism is configured to maintain an open space within the one or more lumens such that outflow of the bodily fluid through the one or more lumens remains unobstructed such that a negative pressure buildup in the cavity is inhibited. The device may also include a vent or valve mechanism in communication with the elongate body to allow air to enter or exit the one or more lumens.Type: ApplicationFiled: August 21, 2020Publication date: December 10, 2020Applicant: Potrero Medical, Inc.Inventors: Evan S. LUXON, Marcie HAMILTON, Daniel R. BURNETT, Mark ZIEGLER